Aradigm Corporation (Nasdaq:ARDM) (the “Company”) announced today that
it will host an Analyst Breakfast on the topic of Non-Cystic Fibrosis
Bronchiectasis (non-CF BE) on Tuesday, August 12, 2014 from 8 am-9:30 am
Eastern Time in New York, NY.
Ares Capital Corporation (“Ares Capital” – NASDAQ:ARCC) is providing
additional details on its financing commitments closed during the second
quarter of 2014, which were included in Ares Capital’s earnings
announcement released yesterday.
Ares Commercial Real Estate Corporation (NYSE: ACRE) announced today
that its wholly owned subsidiary, ACRE Capital LLC, has been approved as
a Seller/Servicer with the Freddie Mac Program Plus® network for
Ares Commercial Real Estate Corporation (the “Company,” “ACRE,” “we,”
and “our”) (NYSE:ACRE), a specialty finance company primarily engaged in
principal lending and mortgage banking of commercial real estate (“CRE”)
investments reported net income of $6.6 million or $0.23 per basic and
diluted common share and $11.4 million or $0.40 per basic and diluted
common share, respectively, for the three and six months ended June 30,
Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial
results for the second quarter of 2014, including revenue from sales of Iclusig ®
(ponatinib). The Company also provided an update on corporate
Astro-Med, Inc. (NASDAQ: ALOT), a leading manufacturer of specialty
high-tech printing systems and data acquisition products, will announce
its second-quarter fiscal 2015 financial results pre-market on
Wednesday, August 20, 2014 and will host a conference call starting at
9:00 a.m. ET.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.